$GSKA potential "ABC" pattern has been located here at a level where two previous support levels were broken. Price is near the 11-2023 support level. Looking for a retracement here to two targets overtime.
GGGSK plc
20.02USDD
−0.98−4.67%
Last update at Jun 16, 15:29 GMT
USD
No tradesPre-market
Key facts today
Next report date
July 30
Report period
Q2 2025
EPS estimate
0.59 USD
Revenue estimate
10.65 B USD
1.00 USD
3.22 B USD
39.25 B USD
3.91 B
About GSK PLC ORD GBP0.3125
Sector
Industry
CEO
Emma N. Walmsley
Website
Headquarters
London
ISIN
GB00BN7SWP63
FIGI
BBG000CVPWL6
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
−8%
0%
8%
16%
24%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−4.00 B
0.00
4.00 B
8.00 B
12.00 B
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
2.50 B
5.00 B
7.50 B
10.00 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
2.50 B
5.00 B
7.50 B
10.00 B
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
6.00 B
12.00 B
18.00 B
24.00 B
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
GSK 1-2 wk swing IdeaNYSE:GSK has set of a daily trigger with a 5/10 ema crossover after a positive earnings report.
During my planning for this idea, I needed to zoom WAY out to the monthly chart in order to understand these levels a bit more. Screen shot of the monthly below:
It turns out that last week's close
GSK (GSK) Outperformed Market ReturnsIn the latest trading session, GSK (GSK) closed at $37.10, marking a +1.23% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.63% for the day. Elsewhere, the Dow gained 0.59%, while the tech-heavy Nasdaq added 0.39%.
Prior to today's trading, shares of the dru
Long Glaxo Smith Kline (NAS:GSK) looks very good risk returnUsing longer term Auction Market Theory to construct longer term meaningful #VolumeProfiles can sometimes provide exceptional risk reward setups.
One has just popped up in GSK according to my read anyway.
Now price has returned into the longer term Value Area there's a very good chance price will
$GSK: Weekly trend signalGreat reward to risk in this weekly chart setup in $GSK, worth a shot, you can probably play it with options to not allocate too much capital in this idea and have limited downside risk. An ITM put spread or some kind of Iron Butterfly OTM can both reap the passage of time profiting from Theta drop
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
17RI
GLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/45Yield to maturity
6.06%
Maturity date
Dec 18, 2045
XS217060907
GLAXOSM.CAP. MTN 20/35MTNYield to maturity
6.02%
Maturity date
May 12, 2035
GSK3981911
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043Yield to maturity
5.90%
Maturity date
Mar 18, 2043
83GI
GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/2042Yield to maturity
5.71%
Maturity date
Apr 10, 2042
71ZC
GLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/39Yield to maturity
5.20%
Maturity date
Mar 9, 2039
GSK.GJ
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038Yield to maturity
5.18%
Maturity date
May 15, 2038
GSK6023693
GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035Yield to maturity
5.14%
Maturity date
Apr 15, 2035
GSK6023692
GlaxoSmithKline Capital Plc FRN 12-MAR-2027Yield to maturity
4.67%
Maturity date
Mar 12, 2027
AG99
GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/2033Yield to maturity
4.61%
Maturity date
Dec 19, 2033
72WI
GLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/2034Yield to maturity
4.57%
Maturity date
Apr 15, 2034
GSK6023695
GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030Yield to maturity
4.55%
Maturity date
Apr 15, 2030
See all GLAXF bonds
Curated watchlists where GLAXF is featured.
Female-led stocks: Who rules the world?
34 No. of Symbols
UK stocks: Best of British
28 No. of Symbols
See all sparks
Frequently Asked Questions
The current price of GLAXF is 20.02 USD — it has decreased by −4.67% in the past 24 hours. Watch GSK plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange GSK plc stocks are traded under the ticker GLAXF.
GLAXF stock has risen by 3.83% compared to the previous week, the month change is a 16.65% rise, over the last year GSK plc has showed a −0.30% decrease.
We've gathered analysts' opinions on GSK plc future price: according to them, GLAXF price has a max estimate of 35.56 USD and a min estimate of 15.82 USD. Watch GLAXF chart and read a more detailed GSK plc stock forecast: see what analysts think of GSK plc and suggest that you do with its stocks.
GLAXF reached its all-time high on Feb 14, 2007 with the price of 37.37 USD, and its all-time low was 13.48 USD and was reached on Sep 26, 2022. View more price dynamics on GLAXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GLAXF stock is 4.90% volatile and has beta coefficient of 0.87. Track GSK plc stock price on the chart and check out the list of the most volatile stocks — is GSK plc there?
Today GSK plc has the market capitalization of 81.76 B, it has increased by 1.56% over the last week.
Yes, you can track GSK plc financials in yearly and quarterly reports right on TradingView.
GSK plc is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
GLAXF earnings for the last quarter are 0.58 USD per share, whereas the estimation was 0.52 USD resulting in a 12.26% surprise. The estimated earnings for the next quarter are 0.59 USD per share. See more details about GSK plc earnings.
GSK plc revenue for the last quarter amounts to 9.71 B USD, despite the estimated figure of 9.54 B USD. In the next quarter, revenue is expected to reach 10.65 B USD.
GLAXF net income for the last quarter is 2.10 B USD, while the quarter before that showed 517.96 M USD of net income which accounts for 304.94% change. Track more GSK plc financial stats to get the full picture.
GSK plc dividend yield was 4.53% in 2024, and payout ratio reached 96.58%. The year before the numbers were 4.00% and 47.69% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 17, 2025, the company has 68.63 K employees. See our rating of the largest employees — is GSK plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GSK plc EBITDA is 11.59 B USD, and current EBITDA margin is 26.18%. See more stats in GSK plc financial statements.
Like other stocks, GLAXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GSK plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GSK plc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GSK plc stock shows the neutral signal. See more of GSK plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.